Vanguard Group Inc Horizon Therapeutics Public LTD CO Transaction History

Vanguard Group Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $4.25 Million - $4.97 Million	42,917 Added 0.2%	21,587,441 $2.5 Billion
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $839,025 - $978,717	-8,709 Reduced 0.04%	21,544,524 $2.22 Billion
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $34 Million - $36 Million	317,130 Added 1.49%	21,553,233 $2.35 Billion
Q4 2022 Feb 10, 2023	SELL	$62.39 - $113.8 $2.53 Million - $4.62 Million	-40,559 Reduced 0.19%	21,236,103 $2.42 Billion
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $20.9 Million - $30 Million	354,287 Added 1.69%	21,276,662 $1.32 Billion

Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $47.1 Million - $69.1 Million	593,498 Added 2.92%	20,922,375 $1.67 Billion
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $16.4 Million - $20.9 Million	190,183 Added 0.94%	20,328,877 $2.14 Billion
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $11.2 Million - $13.6 Million	113,681 Added 0.57%	20,138,694 $2.17 Billion
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $9.09 Million - $10.9 Million	98,861 Added 0.5%	20,025,013 $2.19 Billion
Q2 2021 Aug 13, 2021	BUY	$86.24 - $95.92 $1.72 Billion - $1.91 Billion	19,926,152 New	19,926,152 $1.87 Billion

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.